To evaluate the potential use of UBE2C and MGP as biomarkers for ESCC, we analyzed the protein levels of UBE2C and MGP in 205 training ESCC tumor tissues by immunohistochemistry (IHC). This evidence concerns the gene MGP and neoplasm.